Jack Cuzick

Jack Cuzick is a British academic, a professor and head of the Centre for Epidemiology, Mathematics and Statistics at the Wolfson Institute, Queen Mary University of London.

He is involved in the collection and analysis of data for cancer prevention and screening, particularly for breast, cervical and bowel cancers.[1] He is best known for his role conducting the IBIS trials of tamoxifen and aromatase inhibitors for chemoprevention of breast cancer in women with high risk of developing the disease. For this research, Cuzick's team won Cancer Research UK's Translational Cancer Research Prize in 2014,[2] and Cuzick received the American Cancer Society Medal of Honor in 2015.[3]

References

  1. ↑ "Jack Cuzick". Cancer Research UK. Archived from the original on 2015-04-21. Retrieved 2015-09-04.
  2. ↑ "Translational Cancer Research Prize". Cancer Research UK. 2015-11-02. Retrieved 2015-12-19.
  3. ↑ "Wolfson Institute - Professor Jack Cuzick receives American Cancer Society Medal of Honor | Wolfson Institute". Wolfson.qmul.ac.uk. 2015-10-02. Retrieved 2015-12-19.


This article is issued from Wikipedia - version of the Saturday, December 19, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.